Zimmer Biomet的股票下降, 尽管收入预测不振, 并宣布股息。 Zimmer Biomet's stock dropped despite beating earnings forecasts and declaring a dividend.

Zimmer Biomet是一家医疗技术公司,其股份在星期四从前一天108.25美元下降到104.00美元。 Zimmer Biomet, a medical technology company, saw its shares drop to $104.00 on Thursday, down from $108.25 the previous day. 尽管如此,该公司报告收入略有下降,EPS为2.31美元,分析人员提高了目标价格。 Despite this, the company reported a slight beat on earnings, with EPS of $2.31, and analysts have raised their target prices. Zimmer Biomet的首席执行官强调,该公司最近收购了Paragon 28, 作为其除核心矫形外实现多样化战略的一部分。 Zimmer Biomet's CEO highlighted the company's recent acquisition of Paragon 28 as part of its strategy to diversify beyond core orthopedics. 2025年,该公司预测经调整的EPS为8.15至8.35美元,收入为78-79亿美元。 For 2025, the company forecasts an adjusted EPS of $8.15 to $8.35 and revenue of $7.8-7.9 billion. Zimmer Biomet公司还宣布季度股息为每股0.24美元。 Zimmer Biomet also declared a quarterly dividend of $0.24 per share.